For the Inventor, By the Inventor

Enter assignee name

Vancouver, Canada

Acuitas Therapeutics, Inc.

USPTO Granted Patents = 24

CIPO Patents = 7

EPO Patents = 10

Trademarks = 4

Forward Citations = 344

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Xinyao Du (17 out of 24 patents)

Steven Michial Ansell (14 out of 27 patents)

Xinyao Du (6 out of 6 patents)

4. Julia Gatenyo (3 out of 3 patents)

5. Michael J Hope (2 out of 40 patents)

6. Thomas D Madden (2 out of 24 patents)

7. Paulo Jia Ching Lin (2 out of 2 patents)

8. Barbara Mui (2 out of 4 patents)

9. Christopher J Barbosa (2 out of 2 patents)

10. Christopher James Barbosa (1 out of 2 patents)

11. Jason Samuel Tan (1 out of 1 patent)

12. Stephen Paul Arns (1 out of 1 patent)

13. Polina Blagojevic (1 out of 1 patent)

14. Kody Moleschi (1 out of 1 patent)

15. David Cretney (1 out of 1 patent)

24 patents: Sort by Forward Citations

1. 12491261 - Lipid nanoparticle formulations (2025-12-09),

2. 12410121 - Cationic lipids for use in lipid nanoparticles (2025-09-09),

3. 12329857 - Systems and methods for manufacturing lipid nanoparticles and liposomes (2025-06-17),

4. 12151996 - Lipids for lipid nanoparticle delivery of active agents (2024-11-26),

5. 12129223 - Lipids for use in lipid nanoparticle formulations (2024-10-29),

6. 12065396 - Lipids for use in lipid nanoparticle formulations (2024-08-20),

7. 11976019 - Cationic lipids for use in lipid nanoparticles (2024-05-07),

8. 11820728 - Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids (2023-11-21),

9. 11712481 - Lipid nanoparticle formulations (2023-08-01),

10. 11648324 - Lipids and lipid nanoparticle formulations for delivery of nucleic acids (2023-05-16),

11. 11639329 - Lipids for use in lipid nanoparticle formulations (2023-05-02),

12. 11634379 - Lipids and lipid nanoparticle formulations for delivery of nucleic acids (2023-04-25),

13. 11542225 - Lipids for use in lipid nanoparticle formulations (2023-01-03),

14. 11524932 - Lipids for use in lipid nanoparticle formulations (2022-12-13),

15. 11453639 - Lipids for lipid nanoparticle delivery of active agents (2022-09-27),

Acuitas Therapeutics, Inc. is a leading biotechnology company focused on the development and commercialization of RNA-based therapeutics. Our mission is to harness the power of RNA to treat a wide range of diseases. We are committed to developing innovative therapies that have the potential to significantly improve patient outcomes in areas of high unmet medical need. With a dedicated team of scientists and a strong pipeline of promising candidates, we are driven by the goal of transforming patients' lives through the advancement of RNA therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

24 Patents

#25 in Vancouver

#559 in Canada

#25,825 in the World

Vancouver, Canada

Acuitas Therapeutics, Inc.

Forward Citations = 344

18 inventors:

Xinyao Du (17 out of 24 patents)

Steven Michial Ansell (14 out of 27 patents)

Xinyao Du (6 out of 6 patents)

4. Julia Gatenyo (3 out of 3 patents)

5. Michael J Hope (2 out of 40 patents)

Please report any incorrect information to support@idiyas.com

Loading…